Overview Research

Using our novel method, we have identified unique cancer specific surface antigens on human breast cancer cells and antibodies that can preferentially bind to the antigens and kill the cancer cells.

This method should be applicable to any type of cancer.

The problem with cancer treatments today is they affect normal cells as well as cancer cells. This results in significant pain and suffering by the patient and sometimes death. Solutions against ONLY cancer cells are necessary.

Cancer Antibodies Inc., a cancer research foundation founded by Dr. Elliot Davis, has developed a novel method that identifies unique targets on cancer cells and a delivery means for preferentially killing cancer cells while not harming normal cells.

This is the Holy Grail of cancer treatment.